The patient with testicular cancer: nursing management of chemotherapy.
Although testicular cancer accounts for only one percent of all male malignancies, it affects a predominantly young population (15-35 years). Despite its relatively low incidence, the emotional, financial, and psychosocial implications of the disease and its treatment in this young population are enormous. Knowledge of the disease and its treatment-related side effects and toxicities is essential to planning comprehensive nursing care. This article reviews the natural history, treatment, and nursing management of the client with testicular cancer, focusing on the specific and most current issues associated with this disease and its chemotherapeutic treatment. Application of research findings in the management of both short- and long-term sequelae are discussed.
Higgs
D J
DJ
D000932:Antiemetics / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009325:Nausea / Q000188:drug therapy / Q000451:nursing; D009367:Neoplasm Staging; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000451:nursing* / Q000473:pathology; D014839:Vomiting / Q000188:drug therapy / Q000451:nursing
D000932:Antiemetics